Production / Manufacturing
Pharmaceutical Raw Materials Manufacturing in China
IBISWorld Industry Report
| Publication Date | October 2008 |
| Publisher | IBIS |
| Product Type | Report |
| Pages | 47 |
| ISBN Number | not applicable |
| Product Code | IBI00075 |
Price
approximately: $401 | €296
pdf immediate delivery
Order above formats by FAX
Summary
The IBISWorld Pharmaceutical Raw Materials Manufacturing in China industry report is comprised of establishments primarily engaged in the manufacture of chemical medicine raw materials for further manufacture of finished pharmaceutical products. This industry is within the Chemical Pharmaceutical Manufacturing subsector in China, which includes the manufacture of chemical substances for pharmacy, such as bacteriophage, endocrine products, basic vitamins, sulfanilamide medicine, salicylate, glucose and alkaloids. However, hematic products are not included. This industry acts as a bridge between the upstream chemical industry and the downstream medical market, and is affected not only by the economy and trade, but also by medical insurance levels of China.
Contents
- Industry Definition
- Activities (Products And Services)
- Similar Industries
- Other Related Industries
- Key Statistics
- Current Prices
- Constant Prices
- Real Growth
- Ratio Table
- Segmentation
- Products And Service Segmentation
- Major Market Segments
- Industry Concentration
- Geographic Spread
- Market Characteristics
- Market Size
- Linkages
- Demand Determinants
- Domestic And International Markets
- Basis Of Competition
- Life Cycle
- Industry Conditions
- Barriers To Entry
- Taxation
- Industry Assistance
- Regulation And Deregulation
- Cost Structure
- Capital And Labor Intensity
- Technology And Systems
- Industry Volatility
- Globalization
- Key Factors
- Key Sensitivities
- Key Success Factors
- Key Competitors
- Major Players
- Player Performance
- Other Players
- Industry Performance
- Current Performance
- Historical Performance
- Outlook
